API security measures in financial services - Global Banking & Finance Review
An illustration depicting API security in financial services, highlighting its importance in maintaining customer trust amidst rapid digital innovation. This image emphasizes the critical role of secure APIs in the evolving landscape of open banking.
Research Reports

The global Digital Pathology Market is expected to witness a CAGR of 13.5% during the forecast period (2021 – 2031)

Published by Uma Rajagopal

Posted on January 20, 2022

5 min read

· Last updated: January 28, 2026

Add as preferred source on Google

Global Digital Pathology Market Set for 13.5% CAGR Growth by 2031

 

The digital pathology market has witnessed notable changes in terms of product innovation. One of the major reasons behind this is the scope of cloud integration with pathology outcomes in laboratory operations. According to a recent report by Future Market Insights, the global digital pathology market was valued at USD 6.19 Bn in 2021 and is expected to witness a CAGR of 13.5% during the forecast period (2021 – 2031). The scope of digital pathology with cloud integration has expanded with promising potential for numerous therapies in the healthcare industry including anti-cancer treatments. Innovation in terms of product efficiency, capabilities, and other modalities drives growth in the digital pathology market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-124

A number of modern hospitals are installing newly modified digital pathology systems for their laboratories which has widened the consumer base of the market globally. Manufacturers of digital pathology solutions are constantly making changes in software, to enhance the capabilities and efficacies of digital pathology devices.

This development will provide easy access to information such as images, and will also cater to specialized needs. In 2017, Glencoe Software Inc., launched a software named Path Viewer, which is used in interactive viewing and annotation of digital pathology images.

In Jan 2018, Definiens AG released Tissue Studio 4.2 software package. The updated product suite provided improved image analysis for researchers in academic medical laboratories, comprehensive cancer diagnostic and treatment centers, biotechnology, and pharmaceutical companies.

Key Takeaways of Digital Pathology Market Study

  • Digital pathology equipment is anticipated to increase at a CAGR of 13.7% over 2021-2031, to reach US$ 12.94 Bn by 2031, aided by growing investments by hospitals and laboratories.
  • The clinical pathology and molecular diagnostics segment collectively have gained more than 50% of the market share in terms of revenue owing to use for a wider scope of ailments. 
  • CROs are estimated to display high growth potential at a CAGR of 19.0% in the forecast period owing to cost benefits to end users. 
  • Canada is reflecting high potential for growth with a 14.2% CAGR, driven by the expansion of urban centers and investments into healthcare facilities.
  • The U.K. will account for over 24% of the Europe value share, surpassing Germany by 2031, owing to increases in healthcare research spending.

 

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-124

“Growing research and development initiatives aimed towards cancer diagnosis and treatment are key factors expected to provide major growth opportunities for the digital pathology market through the end of 2031,” says the FMI Analyst.         

Who is Winning?

Leading players in the market are largely focused on product development launches in addition to investing in strategic acquisitions and capacity expansions, to explore previously untapped markets.

Some the prominent players in the digital pathology market are Danaher Corporation, F. Hoffmann-La Roche AG, Huron Technologies International Inc., Koninklijke Philips N.V., Olympus Corporation, Hamamatsu Photonics K.K., Carl Zeiss, 3D HISTECH Ltd.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029. The study provides compelling insights on digital pathology market on basis of component type (systems, software, and services), application (clinical pathology, molecular diagnostics, basic & applied research, drug development, others) and end users (hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, forensic laboratories, research institutes, contract research organizations, and clinics across seven major regions.

For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/askus/rep-gb-124

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

Explore FMI’s Extensive Coverage on Healthcare Domain 

Orthopaedic Imaging Equipment Market The global Orthopedic Imaging Equipment Market was valued at US$ 9.8 Bn in 2021 and is expected to reach US$ 14.6 Bn by 2031. 

Cellulite Treatment Market The global Cellulite Treatment Market is set to enjoy a valuation of US$ 3.3 Bn in 2022, and is predicted to expand at an impressive CAGR of 7.8% to reach a valuation of US$ 5.2 Bn by 2028.

 Enzyme Replacement Therapy Market The global Enzyme Replacement Therapy Market is set to be valued at US$ 9.3 Bn in 2022, and is predicted to expand at a CAGR of 6.7% to attain a net worth of US$ 13.8 Bn by the end of 2028. 

 

About Future Market Insights (FMI) 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reportsand industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. 

 

Contact: 

Future Market Insights, 

1602-6 Jumeirah Bay X2 Tower, 

Plot No: JLT-PH2-X2A, 

Jumeirah Lakes Towers, Dubai, 

United Arab Emirates 

For Sales Enquiries: sales@futuremarketinsights.com 

For Media Enquiries: press@futuremarketinsights.com 

Website: https://www.futuremarketinsights.com/ 

Report: https://www.futuremarketinsights.com/reports/Global-digital-pathology-market
Press Release Sourcehttps://www.futuremarketinsights.com/press-release/Global-digital-pathology-market

Key Takeaways

  • Digital pathology market to grow at 13.5% CAGR from 2021 to 2031.
  • Cloud integration enhances pathology outcomes.
  • CROs show high growth potential with 19.0% CAGR.
  • Canada and the UK are key growth regions.
  • Product innovation drives market expansion.

Frequently Asked Questions

What is the main topic?
The article discusses the growth and innovation in the digital pathology market, with a focus on cloud integration and product development.
What is the expected growth rate?
The digital pathology market is expected to grow at a CAGR of 13.5% from 2021 to 2031.
Which regions are key for growth?
Canada and the UK are highlighted as key regions for growth in the digital pathology market.

Related Articles

More from Research Reports

Explore more articles in the Research Reports category